NCT00478374View on ClinicalTrials.gov

Sorafenib With TACE to Treat Hepatocellular Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Sorafenib

Sorafenib 400mg bid

PROCEDURE

Transarterial chemoembolisation with doxorubicin

Transarterial chemoembolisation (TACE)

Trial Locations (1)

3010

Inselspital, Bern

All Listed Sponsors
lead

University of Bern

OTHER

NCT00478374 - Sorafenib With TACE to Treat Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter